IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 85 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission

 


This article has been cited by
1Destination of aminoglycoside antibiotics in the ‘post-antibiotic era’
Yoshiaki Takahashi,Masayuki Igarashi
The Journal of Antibiotics.2018;71(1)4
[DOI]
2A structure-based strategy toward the development of novel candidates for antimycobacterial activity: Synthesis, biological evaluation, and docking study
Linhu Li,Yuanyuan Jin,Bin Wang,Zhaoyong Yang,Mingliang Liu,Huiyuan Guo,Jun Zhang,Yu Lu
Chemical Biology & Drug Design.2018;91(3)769
[DOI]
3New Ways to Treat Tuberculosis Using Dendrimers as Nanocarriers
Serge Mignani,Rama Tripathi,Liang Chen,Anne-Marie Caminade,Xiangyang Shi,Jean-Pierre Majoral
Pharmaceutics.2018;10(3)105
[DOI]
4Mycobacterial tryptophan biosynthesis: A promising target for tuberculosis drug development?
Sara Consalvi,Cristina Scarpecci,Mariangela Biava,Giovanna Poce
Bioorganic & Medicinal Chemistry Letters.2019;10(3)126731
[DOI]
5The Emergence of Phenolic Glycans as Virulence Factors in Mycobacterium tuberculosis
Danielle D. Barnes,Mimmi L. E. Lundahl,Ed C. Lavelle,Eoin M. Scanlan
ACS Chemical Biology.2017;12(8)1969
[DOI]
6The Emergence of Phenolic Glycans as Virulence Factors in Mycobacterium tuberculosis
Corliss A. O’Bryan,Philip G. Crandall,Steven C. Ricke
ACS Chemical Biology.2018;12(8)99
[DOI]
7Mycobacterial protein tyrosine kinase, PtkA phosphorylates PtpA at tyrosine residues and the mechanism is stalled by the novel series of inhibitors
Swati Jaiswal,Aditi Chatterjee,Sapna Pandey,Kiran Lata,Ranjith Kumar Gadi,Rajesh Manda,Sanjay Kumar,Maddi Sridhar Reddy,Ravishankar Ramachandran,Kishore K. Srivastava
Journal of Drug Targeting.2019;27(1)51
[DOI]
8Strategies towards the synthesis of anti-tuberculosis drugs
Haridas B. Rode,Dhanaji M. Lade,René Grée,Prathama S. Mainkar,Srivari Chandrasekhar
Organic & Biomolecular Chemistry.2019;17(22)5428
[DOI]
9Chitosan nanoparticles as a promising approach for pulmonary delivery of bedaquiline
Tejal Rawal,Snehal Patel,Shital Butani
European Journal of Pharmaceutical Sciences.2018;124(22)273
[DOI]
10Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations
Shalini Saxena,Maaged Abdullah,Dharmarajan Sriram,Lalitha Guruprasad
Journal of Biomolecular Structure and Dynamics.2018;36(12)3184
[DOI]
11Synthesis, Characterization, Molecular Docking Studies and Biological Evaluation of Some Conjugated Quinazoline-Sulfonamide Scaffold
A. Sunil Kumar,Jyothi Kudva,B. R. Bharath,Vaishali M Rai,S. Madan Kumar,Vasantha Kumar,Shyama Prasad Sajankila
ChemistrySelect.2018;3(48)13586
[DOI]
12Trends in the discovery of new drugs for Mycobacterium tuberculosis therapy with a glance at resistance
Vahid Lohrasbi,Malihe Talebi,Abed Zahedi Bialvaei,Lanfranco Fattorini,Michel Drancourt,Mohsen Heidary,Davood Darban-Sarokhalil
Tuberculosis.2018;109(48)17
[DOI]
13Bedaquiline and delamanid in tuberculosis
Susanna Esposito,Sonia Bianchini,Francesco Blasi
Expert Opinion on Pharmacotherapy.2015;16(15)2319
[DOI]
14The effect of surgery on the outcome of treatment for multidrug-resistant tuberculosis: a systematic review and meta-analysis
Rebecca C. Harris,Mishal S. Khan,Laura J. Martin,Victoria Allen,David A. J. Moore,Katherine Fielding,Louis Grandjean
BMC Infectious Diseases.2016;16(1)2319
[DOI]
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow